Article -> Article Details
| Title | South Korea Diabetes Devices Market Size, Share, Industry Overview, Trends and Forecast 2025-2033 |
|---|---|
| Category | Business --> Healthcare |
| Meta Keywords | South Korea Diabetes Devices Market |
| Owner | Ashutosh SEO |
| Description | |
| IMARC Group has recently released a new research study titled “South Korea Diabetes Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2026-2034”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. South Korea Diabetes Devices Market Overview The South
Korea diabetes devices market size reached USD 366.04 Million in 2025.
It is expected to grow at a CAGR of 8.10% during the forecast period of
2026-2034, reaching USD 775.52 Million by 2034. Growth is driven by increased
diabetes prevalence, advancement in glucose monitoring technologies, government
healthcare initiatives, and rising adoption of telemedicine and mobile health
solutions. Study Assumption Years
South Korea Diabetes Devices Market Key Takeaways
Sample Request Link: https://www.imarcgroup.com/south-korea-diabetes-devices-market/requestsample Market Growth Factors The South Korea diabetes devices market is propelled by a
rise in diabetes prevalence combined with increased awareness about early
diagnosis and effective management. Government initiatives aimed at healthcare
improvement further stimulate market demand. The adoption of advanced glucose
monitoring technologies and telemedicine solutions supports better disease
control. These factors collectively contribute to robust market growth
forecasted at a CAGR of 8.10% between 2026 and 2034. Digital integration with chronic disease management
applications facilitates real-time monitoring of blood glucose, nutrition,
exercise, and medication. Innovations such as the SoloSmart and Health2Sync's
"SugarGenie" app enhance treatment adherence by offering seamless
tracking and insulin management in Korean language, improving patient outcomes
through personalized, data-driven care. Innovation in continuous glucose monitoring also drives
growth, marked by the launch of the locally manufactured CareSens Air CGM
device by i-SENS. Certified by the Ministry of Food and Drug Safety, this
device is noted for being the smallest and lightest, providing 15 days of use
and enhanced calibration. Its potential for expansion to international markets
including Europe after CE certification reflects the growing domestic
technological advancements influencing the market. Market Segmentation Type Insights:
Distribution Channel Insights:
Ask For an Analyst- https://www.imarcgroup.com/request?type=report&id=28718&flag=C Regional Insights The report categorizes the market into major regions
including the Seoul Capital Area, Yeongnam (Southeastern Region), Honam
(Southwestern Region), Hoseo (Central Region), and others. The analysis
highlights the Seoul Capital Area as a key market region due to its dense
population and healthcare infrastructure. Recent Developments & News In February 2025, Health2Sync's SugarGenie app strengthened
its presence in South Korea's diabetes treatment market by enhancing diabetes
monitoring and control in hospitals and government programs. It became active
in over 100 healthcare facilities by December 2024. In May 2024, Kakao
Healthcare partnered with Rumah Sakit Universitas Indonesia (RSUI) to launch
Pasta, an AI-powered diabetes management smartphone app that integrates with
continuous glucose monitors to provide real-time glucose measurements and
lifestyle suggestions. About Us IMARC Group is a global management consulting firm that
helps the world’s most ambitious changemakers to create a lasting impact. The
company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies,
company incorporation assistance, factory setup support, regulatory approvals
and licensing navigation, branding, marketing and sales strategies, competitive
landscape and benchmarking analyses, pricing and cost research, and procurement
research. Contact Us IMARC Group, 134 N 4th St. Brooklyn, NY 11249, USA, Email: sales@imarcgroup.com, Tel No: (D) +91 120 433 0800, United States: +1-201971-6302 | |